The 2026 BioIntellect Oncology West Coast Summit is an exclusive, one-day summit for senior leaders shaping the future of oncology drug therapeutics.

Taking place in San Diego, the Summit convenes over 60 handpicked executives for focused, closed-door conversations around the scientific, operational, and data challenges driving next-generation cancer therapeutics. This is not a traditional conference. It’s an environment for real dialogue, real problems, and real progress.

The agenda is structured around three high-impact tracks:

🔹 Translational & Biomarker Strategy
Dive into the mechanistic underpinnings of response and resistance. Topics include patient stratification strategies, spatial and single-cell technologies, liquid biopsy validation, and the integration of translational endpoints into clinical design.

🔹 Oncology Trial Operations
Explore how oncology trials are being re-engineered in the face of increasing protocol complexity, global site constraints, and heightened regulatory expectations. Sessions address trial acceleration, patient recruitment, and operational risk management in a competitive ecosystem.

🔹 Data & Trial Oversight
Engage with evolving approaches to data visibility, trial monitoring, and endpoint analysis. From digital biomarkers and remote data capture to adaptive oversight and audit-readiness, this track focuses on building intelligent trial infrastructure for modern oncology programs.

Spotlights & Keynotes offer perspective from the top: R&D executives and scientific leaders sharing what’s changing, what’s breaking, and what’s next in oncology strategy and execution.

At the center of the experience: closed-door roundtables — confidential, small-group discussions that cut through noise and surface pragmatic insights among true peers.